Delivery Order SPE2DB24D9105-SPE2DB25FBYVF
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on August 8, 2025. The contract, with an ultimate completion date of August 11, 2025, provides for the delivery of Jakafi 10 mg tablets (60-count units) under a firm fixed-price arrangement. This delivery order was issued without a set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 7, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025, with performance to be executed in Park Ridge, Illinois. The award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $24.0K firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the supply of Jakafi 15 mg tablets (60-count units). The delivery order is expected to be completed by September 4, 2025, with performance taking place at the contractor's Park Ridge facility. This award carries no set-aside designation, allowing...
- The U.S. Department of Defense Medical Supply Chain awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $36,346.95 for Jakafi 10 mg tablets (60-count units). Issued on September 2, 2025, with an ultimate completion date of September 3, 2025, this firm fixed-price delivery order carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,191.59 by the Defense Logistics Agency on May 30, 2025, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, which carries an ultimate completion date of June 2, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,462.60 by the Defense Logistics Agency on July 11, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 14, 2025, was issued without a set-aside designation. The contract is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for 60 tablets of Jakafi 20 mg with a ceiling value of $148,965.28. The award, issued on September 16, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This delivery order carries no set-aside designation and represents a single product...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,293.60 on July 28, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract, which carries no set-aside designation, is issued under DMS's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026. This delivery order will be...
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on April 22, 2025, for the supply of Jakafi 10 mg tablets (60-count). The order, which carries no set-aside designation, is scheduled for completion by April 23, 2025, and will be performed at the vendor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical...
- SPE2DB24D9105Indefinite Delivery Contract
- SPE2DB24D9105-SPE2DB25FBYVFDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 26, 2025, for the supply of Jakafi 5 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $12,146.79. The Defense Logistics Agency, a component of the Department of Defense, issued this award without a set-aside designation to support military healthcare supply requirements. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables for Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain through its consistent performance on Department of Defense contracts. The company's extensive experience distributing specialty medications—including oncology treatments, vaccines, and other prescription pharmaceuticals—demonstrates its capability to meet the critical medical supply needs of military health facilities. The contract specifies a place of performance in Park Ridge, Illinois, with an ultimate completion date of August 27, 2025, reflecting the expedited delivery requirements typical of defense pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/26/25 |